Back to results
US 10,227,299 B2Granted
3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
AssigneeBayer Pharma Aktiengesellschaft
InventorsKeith Graham, Ulrich Klar, Hans Briem, Gerhard Siemeister, Ursula Mönning, Jozsef Balint
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I) as described herein processes for their production and their use as anti-cancer agents.
Claims7
A compound of formula (I),
- wherein:
- R1 is hydrogen or C1-C6-alkyl;
- R2 is hydroxy, C2-C4-alkenyl, R7R8N—, R10—O—C(O)—, R7R8N—C(O)—, R6—C(O)—NR9—, or R11—(C1-C4-alkyl)-,
- wherein said C2-C4-alkenyl is optionally substituted with halogen, R10—O—C(O)—, R7R8N- or phenyl, wherein said phenyl group is optionally substituted, one or more times with R4;
- R3 is hydrogen or C1-C6-alkyl;
- A is a group selected from:
- wherein * indicates the point of attachment of said group with the rest of the molecule and said group is optionally substituted, one or more times with R4;
- each R4 is independently halogen, hydroxy, nitro, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl, C1-C4-haloalkoxy, C1-C4-hydroxyalkyl, C1-C4-alkyl-C(O)—, R10—O—C(O)—, R7R8N—C(O)—, C1-C4-alkyl-C(O)—NH—, R7R8N—, or R7R8N—SO2—;
- E is a group
- wherein * indicates the point of attachment of said group with the rest of the molecule;
- each R5 is independently halogen, hydroxy, nitro, cyano, R9R10N—, (R13—C(O)—)(R14—C(O)—)N—, C1-C4-alkyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C1-C4-haloalkyl, C1-C6-haloalkoxy, R6—C(O)—NR9— or R7R8N—C(O)—NR9—,
- wherein said C1-C4-alkoxy is optionally substituted, one or more times, independently from each other, with a substituent selected from hydroxy, C1-C4-alkoxy, C3-C6-cycloalkyl, and 4- to 6-membered heterocycloalkyl;
- Q is O or N—OH;
- each R6 is independently C1-C6-alkyl, C3-C6-cycloalkyl, 4- to 6-membered heterocycloalkyl, phenyl or heteroaryl,
- wherein said C1-C6-alkyl is optionally substituted, one or more times, independently from each other, with halogen, hydroxy, nitro, cyano, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, R7R8N- or phenyl optionally substituted, one or more times with R4,
- wherein said C3-C6-cycloalkyl, 4- to 6-membered heterocycloalkyl, phenyl or heteroaryl groups are optionally substituted, one or more times, independently from each other, with halogen, hydroxy, nitro, cyano, C1-C6-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl, R10—O—C(O)— or C1-C4-haloalkoxy;
- R7 and R8 are independently hydrogen, C1-C6-alkyl, C3-C6-cycloalkyl, R10—O—C(O)— or phenyl,
- wherein said C1-C6-alkyl is optionally substituted, one or more times, independently from each other, with halogen, hydroxy, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl optionally substituted one time with hydroxy, 4- to 6-membered heterocycloalkyl, heteroaryl, or R9R10N—,
- wherein said phenyl group is optionally substituted, one or more times with R4;
- or,
- R7 and R8 together with the nitrogen atom to which they are attached form a 4- to 7-membered nitrogen containing heterocyclic ring, optionally containing one additional heteroatom selected from O, NR9 and S, and which may be optionally substituted, one or more times with R12;
- wherein two R12 substituents attached to the same ring carbon atom are optionally taken together with the carbon atom to which they are attached to form a cyclobutane, azetidine, or oxetane group;
- said azetidine being optionally substituted one time with C1-C3-alkyl;
- or,
- R7 and R8 together with the nitrogen atom to which they are attached form a group selected from:
- wherein * indicates the point of attachment of said group with the rest of the molecule;
- R9 is hydrogen or C1-C6-alkyl;
- R10 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl;
- R11 is hydroxy, nitro, cyano, C3-C6-cycloalkyl, 4- to 6-membered heterocycloalkyl, C1-C4-alkyl-C(O)—, R10—O—C(O)—, R7R8N—C(O)—, C1-C4-alkoxy, C1-C4-haloalkoxy, R7R8N—, N3—, R6—C(O)—NR9—, R6—O—C(O)—NR9—, R7R8N—C(O)—NR9—, R6—SO2—NR9—, R6—S—, R6—SO—, R6—SO2—, or R7R8N—SO2—,
- wherein said C3-C6-cycloalkyl or 4- to 6-membered heterocycloalkyl groups are optionally substituted, one or more times, independently from each other, with halogen, hydroxy, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl or C1-C4-haloalkoxy,
- wherein said C1-C4-alkoxy is optionally substituted with phenyl,
- wherein said phenyl group is optionally substituted, one or more times with R4;
- each R12 is independently halogen, hydroxy, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl, C1-C4-haloalkoxy, or R9R10N—;
- R13 and R14 are independently C1-C4-alkyl, or C3-C6-cycloalkyl,
- wherein said C3-C6-cycloalkyl is optionally substituted, one or more times, independently from each other, with halogen;
- and
- m is 0, 1 or 2;
- or an N-oxide, a salt, a tautomer or a stereoisomer of said compound, or a salt of said N-oxide, tautomer or stereoisomer.
35 more elements
Dependencies are inferred from the claim text.